Analysis in a group dosing study [Bioanalytics]

posted by jag009  – NJ, 2015-07-22 18:23 (3638 d 16:09 ago) – Posting: # 15127
Views: 3,876

Hi,

❝ We are planning to conduct a FDA submission study in 3 groups (due to logistic limitations).


Is this a parallel study or a crossover study with groups?

You have a timeline issue? If not, I would prefer to finish all dosing and PK samplings before starting bioanalytical.

John

Complete thread:

UA Flag
Activity
 Admin contact
23,428 posts in 4,929 threads, 1,690 registered users;
82 visitors (0 registered, 82 guests [including 8 identified bots]).
Forum time: 10:33 CEST (Europe/Vienna)

Anyone who conducts an argument by appealing to authority
is not using his intelligence;
he is just using his memory.    Leonardo da Vinci

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5